March 30, 2026

Alcon Inc. (ALC) Stock Analysis: Evaluating a 29.95% Potential Upside in the Healthcare Sector

Alcon Inc. (NYSE: ALC), a leader in the Medical Instruments & Supplies industry, presents a compelling case for investors seeking growth in the healthcare sector. With a market capitalization of..

Royalty Pharma plc (RPRX): Investor Outlook Reveals 11.23% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) is a unique player within the healthcare sector, specializing in acquiring biopharmaceutical royalties and funding innovation across the biotechnology industry. With a substantial market capitalization..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with 15.99% Potential Upside

McKesson Corporation (MCK), a leading entity in the healthcare sector, stands as a colossal figure in the medical distribution industry. With a market capitalization of $106.17 billion, it operates extensively..

Exact Sciences Corporation (EXAS)

⚠️ No article content returned.

..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with 12.77% Upside Potential

Exelixis, Inc. (NASDAQ: EXEL) stands as a prominent player in the biotechnology industry, focusing on the discovery and development of treatments for difficult-to-treat cancers. With a market capitalization of $11.13..

Edwards Lifesciences (EW) Stock Analysis: A 22% Upside Potential in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW) presents a compelling investment opportunity for those interested in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $46.08 billion,..

Zoetis Inc. (ZTS) Stock Analysis: Unpacking the 33% Potential Upside for Investors

Zoetis Inc. (NYSE: ZTS), a leader in the animal health industry, presents an intriguing proposition for investors with its current market conditions and potential upside. With a market capitalization of..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A 38.75% Potential Upside in Healthcare Innovation

Neurocrine Biosciences, Inc. (NBIX) is making strides in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $12.88 billion, this San Diego-based..

Quest Diagnostics (DGX) Stock Analysis: Exploring a 11.76% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, is drawing attention with its robust potential for growth and stability in the diagnostics and research industry. With..

STERIS plc (STE) Stock Analysis: Exploring a 27.30% Upside Potential in the Medical Devices Sector

For investors with an eye on the healthcare sector, STERIS plc (NYSE: STE) offers an intriguing prospect in the medical devices industry. With its extensive portfolio of infection prevention products..

Amgen Inc. (AMGN) Investor Outlook: Evaluating a Solid Healthcare Player with Limited Upside Potential

Amgen Inc. (NASDAQ: AMGN), a heavyweight in the healthcare sector, stands as a formidable player among drug manufacturers, boasting a substantial market capitalization of $188.01 billion. Headquartered in Thousand Oaks,..

Incyte Corporation (INCY) Stock Analysis: Exploring a Potential 18% Upside in the Biotechnology Sector

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, is currently attracting attention from investors due to its robust growth potential and a promising product pipeline. With a..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 44% Potential Upside with Strong Buy Ratings

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust performance and promising growth trajectory. Based in Basel, Switzerland, this..

Medtronic plc (MDT): Investor Outlook Highlights 27% Potential Upside

Medtronic plc (NYSE: MDT) is a giant in the healthcare sector, specifically within the medical devices industry, with a commanding market capitalization of $111.88 billion. Headquartered in Galway, Ireland, the..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 12.4% Upside in a Volatile Market

Molina Healthcare Inc (NYSE: MOH), a key player in the healthcare plans industry, presents an intriguing opportunity for investors despite a recent dip in its stock price. With a market..

Mettler-Toledo International (MTD) Stock Analysis: Potential Upside Amidst Strong Revenue Growth

Mettler-Toledo International Inc. (NYSE: MTD), a leader in precision instruments and services, stands as a significant player in the healthcare sector, specializing in diagnostics and research. With a robust market..

GSK plc (GSK) Stock Analysis: A Healthcare Giant with a 6.76% Potential Upside

For investors seeking opportunities in the healthcare sector, GSK plc (GSK) presents an intriguing proposition. As a prominent player in the drug manufacturing industry with a market capitalization of $108.45..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: A 40% Upside Potential Backed by Strong Buy Ratings

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a formidable player within the healthcare sector, specifically in the diagnostics and research industry. With a robust market capitalization of $175.85 billion,..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Hologic, Inc. (HOLX) Investor Outlook: Navigating Growth in the Medical Instruments Sector

Hologic, Inc. (NASDAQ: HOLX), a leader in the healthcare sector specializing in medical instruments and supplies, presents an intriguing case for investors focused on the intersection of technology and women’s..

Search

Funds

March 30, 2026

Search

Funds

March 30, 2026

FTSE 100

Funds